The national clinical trial to identify treatments that may be beneficial for patients diagnosed with COVID-19 will begin recruiting children and infants in May 2020.
Leading paediatricians in the UK have set out a working definition of an inflammatory syndrome affecting a very small number of children and which may be associated with COVID-19.
Most children are asymptomatic or exhibit mild symptoms from COVID-19 infection. However, a small number have been identified who develop a significant systemic inflammatory response, which is also known as PIMS-TS or PIMS). In September 2020 a national consensus management pathway was published to ...
Professor Russell Viner, President of RCPCH, responds to a pre-print (non peer reviewed) study which suggests that children who have COVID-19 may have the same levels of circulating virus in their body as adults.
RCPCH is launching a new data collection and reporting tool to track the impact of COVID-19 on child health services. Dr Jay and Professor Bishop explain why it is so important to capture changes to services during this period.